Cargando…

Defueling the cancer: ATP synthase as an emerging target in cancer therapy

Reprogramming of cellular metabolism is a hallmark of cancer. Mitochondrial ATP synthase (MAS) produces most of the ATP that drives the cell. High expression of the MAS-composing proteins is found during cancer and is linked to a poor prognosis in glioblastoma, ovarian cancer, prostate cancer, breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Ma, Fei, Qian, Hai-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517097/
https://www.ncbi.nlm.nih.gov/pubmed/34703878
http://dx.doi.org/10.1016/j.omto.2021.08.015